TW202306579A - Red yeast rice and composition containing specific components - Google Patents

Red yeast rice and composition containing specific components Download PDF

Info

Publication number
TW202306579A
TW202306579A TW111115867A TW111115867A TW202306579A TW 202306579 A TW202306579 A TW 202306579A TW 111115867 A TW111115867 A TW 111115867A TW 111115867 A TW111115867 A TW 111115867A TW 202306579 A TW202306579 A TW 202306579A
Authority
TW
Taiwan
Prior art keywords
mass
comparative example
component
red yeast
yeast rice
Prior art date
Application number
TW111115867A
Other languages
Chinese (zh)
Inventor
比嘉悠貴
立木賢輔
Original Assignee
日商小林製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商小林製藥股份有限公司 filed Critical 日商小林製藥股份有限公司
Publication of TW202306579A publication Critical patent/TW202306579A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/121Ketones acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

To provide a composition having an enhanced antioxidant activity. This composition contains component (1) and component (2). Component (1) is at least one selected from the group consisting of bisdemethoxycurcumin, glycerine fatty acid ester, diosmetin, linolenic acid, carotene, daidzein, hesperidin, genistein, citrus fruit extract, a processed product of black ginger, naringin, and naringenin. Component (2) is at least one selected from the group consisting of red yeast rice and a processed product thereof.

Description

含有紅麴及特定成分的組成物Compositions containing red yeast rice and specific ingredients

本發明是有關於一種含有紅麴及特定成分的組成物、抗氧化作用的增強方法等。The present invention relates to a composition containing red yeast rice and specific components, a method for enhancing anti-oxidation and the like.

氧於維持生命方面重要,被取入至體內的氧的一部分變化為活性氧,其引起細胞或組織中的氧化壓力(oxidative stress)。已知有體內的氧化壓力成為以動脈硬化、抗炎症、糖尿病、血液的黏度的上升、血管功能的降低為首的各種疾病的原因。Oxygen is important for maintaining life, and a part of the oxygen taken into the body changes into active oxygen, which causes oxidative stress in cells or tissues. Oxidative stress in the body is known to cause various diseases including arteriosclerosis, anti-inflammation, diabetes, increase in blood viscosity, and decrease in vascular function.

先前,就緩和此種氧化壓力的方面而言,著眼於抗氧化,例如已知有以雙去甲氧基薑黃素(bisdemethoxycurcumin)、胡蘿蔔素(carotene)、大豆黃酮(daidzein)、橙皮苷(hesperidin)、金雀異黃酮(genistein)為首的各種成分具有抗氧化作用。另外,為了獲得更高的抗氧化作用,例如已知有一種美容組成物,其含有作為抗氧化物質的松樹皮、以及選自藥草(herb)、腦醯胺(ceramide)及硒中的至少一種素材(專利文獻1)。先前,雖然具有抗氧化作用的製劑等被廣為人知,但是於如此的今天,再者,提供進一步提高了抗酸作用的製品亦重要。 [現有技術文獻] [專利文獻] Previously, anti-oxidation has been focused on alleviating this oxidative stress. For example, bisdemethoxycurcumin, carotene, daidzein, hesperidin ( Various ingredients including hesperidin and genistein have antioxidant effects. In addition, in order to obtain a higher antioxidant effect, for example, a beauty composition is known, which contains pine bark as an antioxidant substance, and at least one selected from the group consisting of herbs (herb), ceramide (ceramide), and selenium. Material (Patent Document 1). Previously, preparations and the like having an antioxidative effect were widely known, but in today's state, it is also important to provide a product with a further enhanced antiacid effect. [Prior art literature] [Patent Document]

[專利文獻1]日本專利特開2021-54770號公報[Patent Document 1] Japanese Patent Laid-Open No. 2021-54770

[發明所欲解決之課題] 本揭示的目的在於提供增強了抗氧化作用的組成物等。 [Problem to be Solved by the Invention] The object of this disclosure is to provide a composition etc. which enhanced the antioxidation effect.

[解決課題之手段] 本發明者們為了解決所述課題而反覆努力研究,結果發現:藉由將紅麴與雙去甲氧基薑黃素等特定成分加以組合,可於含有該特定成分的組成物中增強抗氧化作用。本發明是基於所述見解,並藉由進一步反覆研究而完成者。例如,本揭示包含下述態樣。 項1. 一種組成物,含有下述成分(1)及成分(2): (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素(diosmetin)、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷(naringin)及柚苷配基(naringenin)所組成的群組中的至少一種; (2)選自由紅麴及其加工物所組成的群組中的至少一種。 項2. 如項1所述的組成物,用於經口用途。 項3. 一種組成物中的抗氧化作用增強方法,所述組成物含有下述成分(1),所述方法的特徵在於將下述成分(1)與成分(2)加以組合: (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷及柚苷配基所組成的群組中的至少一種; (2)選自由紅麴及其加工物所組成的群組中的至少一種。 項4. 一種選自由紅麴及其加工物所組成的群組中的至少一種的用途,用以於含有下述成分(1)的組成物中增強抗氧化作用: (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷及柚苷配基所組成的群組中的至少一種。 [發明的效果] [Means to solve the problem] The inventors of the present invention have worked hard to solve the above-mentioned problems, and as a result, they have found that by combining specific components such as red yeast rice and bisdemethoxycurcumin, the antioxidant effect can be enhanced in a composition containing the specific components. . The present invention is based on the above findings and has been completed through further repeated studies. For example, this disclosure includes the following aspects. Item 1. A composition comprising the following components (1) and (2): (1) Bisdemethoxy curcumin, glycerin fatty acid ester, diosmetin, linoleic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black At least one selected from the group consisting of processed ginger, naringin and naringenin; (2) At least one selected from the group consisting of red yeast rice and its processed products. Item 2. The composition according to Item 1, for oral use. Item 3. A method for enhancing antioxidant action in a composition containing the following component (1), the method characterized by combining the following component (1) and component (2): (1) Processed from bis-demethoxy curcumin, glycerin fatty acid ester, diosmin, sub-linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger At least one of the group consisting of naringin, naringin and naringenin; (2) At least one selected from the group consisting of red yeast rice and its processed products. Item 4. Use of at least one selected from the group consisting of red yeast rice and its processed products, for enhancing the antioxidant effect in a composition containing the following component (1): (1) Processed from bis-demethoxy curcumin, glycerin fatty acid ester, diosmin, sub-linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger At least one of the group consisting of naringin, naringin and naringenin. [Effect of the invention]

可提供一種含有所述成分(1)與所述成分(2)的組成物。藉由將所述成分(1)與所述成分(2)加以組合,可於含有所述成分(1)的組成物中增強抗氧化作用。可提供一種所述成分(2)的用途,用以於含有所述成分(1)的組成物中增強抗氧化作用。A composition containing the component (1) and the component (2) can be provided. By combining the component (1) and the component (2), the antioxidant action can be enhanced in the composition containing the component (1). A use of the component (2) may be provided for enhancing the antioxidant effect in a composition containing the component (1).

以下,對本揭示中所包含的實施形態進行更詳細說明。Hereinafter, the embodiments included in the present disclosure will be described in more detail.

本揭示中所包含的組成物含有下述成分(1)及成分(2)。 (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷及柚苷配基所組成的群組中的至少一種; (2)選自由紅麴及其加工物所組成的群組中的至少一種。 The composition included in this disclosure contains the following component (1) and component (2). (1) Processed from bis-demethoxy curcumin, glycerin fatty acid ester, diosmin, sub-linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger At least one of the group consisting of naringin, naringin and naringenin; (2) At least one selected from the group consisting of red yeast rice and its processed products.

成分(1) 成分(1)可如以下般進行說明。雙去甲氧基薑黃素為化學式C 19H 16O 4所表示的公知的物質,且作為CAS編號24939-16-0、33171-05-0而被人知。雙去甲氧基薑黃素可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的雙去甲氧基薑黃素的例子,可列舉Bisdemethoxycurcumin(東京化成工業股份有限公司)等。 Component (1) Component (1) can be demonstrated as follows. Bisdemethoxycurcumin is a known substance represented by the chemical formula C 19 H 16 O 4 and is known as CAS Nos. 24939-16-0 and 33171-05-0. Bisdemethoxycurcumin may be a natural product or a synthetic product, and may be obtained commercially or from a commercially available product, and is not particularly limited. Examples of commercially available bisdemethoxycurcumin include Bisdemethoxycurcumin (Tokyo Chemical Industry Co., Ltd.).

甘油脂肪酸酯為甘油與脂肪酸的酯,於本揭示中,甘油脂肪酸酯包含聚甘油脂肪酸酯、有機酸單甘油酯。甘油脂肪酸酯可為單酯、二酯、三酯的任一種,甘油的聚合度亦無限制,可例示:甘油單脂肪酸酯、甘油二脂肪酸酯、甘油三脂肪酸酯、平均聚合度為2以上的甘油與脂肪酸的酯即聚甘油脂肪酸酯等。Glycerin fatty acid esters are esters of glycerin and fatty acids. In this disclosure, glycerin fatty acid esters include polyglycerin fatty acid esters and organic acid monoglycerides. Glycerin fatty acid esters may be monoesters, diesters, or triesters, and the degree of polymerization of glycerol is not limited, and examples include: glycerin monofatty acid esters, glycerin difatty acid esters, triglycerin fatty acid esters, average degree of polymerization It is an ester of 2 or more glycerin and a fatty acid, that is, a polyglyceryl fatty acid ester, and the like.

雖只要可獲得本揭示的效果,則並無特別限制,但構成甘油脂肪酸酯的脂肪酸的碳數較佳為可例示1~30,更佳為可例示10~25,進而佳為可例示18~21。構成甘油脂肪酸酯的脂肪酸可為直鏈狀、分支鏈狀,另外,可為飽和、不飽和。雖並不限制本揭示,但於聚甘油脂肪酸酯中,甘油的平均聚合度更佳為可例示2~10的整數,進而佳為可例示2~8的整數,特佳為可例示2~6的整數,有機酸單甘油酯中的有機酸若為先前公知的有機酸,則並無限制。It is not particularly limited as long as the effect of the present disclosure can be obtained, but the carbon number of the fatty acid constituting the glycerin fatty acid ester is preferably exemplified from 1 to 30, more preferably exemplified from 10 to 25, and still more preferably exemplified from 18 ~21. The fatty acid constituting glycerin fatty acid ester may be linear or branched, and may be saturated or unsaturated. Although this disclosure is not limited, in polyglycerol fatty acid esters, the average degree of polymerization of glycerin is more preferably an integer of 2 to 10, more preferably an integer of 2 to 8, particularly preferably 2 to 8. is an integer of 6, and the organic acid in the organic acid monoglyceride is not limited as long as it is a conventionally known organic acid.

作為此種脂肪酸,可例示:月桂酸、肉豆蔻酸、棕櫚酸、棕櫚油酸、油酸、反-11-十八烯酸(vaccenic acid)、亞麻油酸、硬脂酸、辛酸、癸酸、次亞麻油酸、山萮酸、乙酸、丙酸、丁酸、乳酸、琥珀酸、己酸、異丁酸、異戊酸、戊酸等。作為脂肪酸,更佳為可例示:油酸、亞麻油酸、硬脂酸、丁酸、乳酸、琥珀酸等。脂肪酸可單獨使用一種,亦可任意組合使用兩種以上。Examples of such fatty acids include lauric acid, myristic acid, palmitic acid, palmitoleic acid, oleic acid, trans-11-octadecenoic acid (vaccenic acid), linoleic acid, stearic acid, caprylic acid, capric acid , Linolenic acid, behenic acid, acetic acid, propionic acid, butyric acid, lactic acid, succinic acid, caproic acid, isobutyric acid, isovaleric acid, valeric acid, etc. As fatty acid, more preferably, oleic acid, linolenic acid, stearic acid, butyric acid, lactic acid, succinic acid, etc. can be illustrated. One type of fatty acid may be used alone, or two or more types may be used in any combination.

作為甘油脂肪酸酯的具體例,只要可獲得本揭示的效果,則並無特別限制,可列舉:乙酸單甘油酯、乳酸單甘油酯、檸檬酸單甘油酯、二乙醯基酒石酸單甘油酯、琥珀酸單甘油酯、甘油單脂肪酸酯、甘油二脂肪酸酯、聚甘油脂肪酸酯、聚甘油縮合蓖麻油酸酯等。甘油脂肪酸酯可單獨使用一種,亦可組合使用兩種以上。Specific examples of fatty acid esters of glycerol are not particularly limited as long as the effect of the present disclosure can be obtained, and examples include monoglyceryl acetate, monoglyceryl lactate, monoglyceryl citric acid, and monoglyceryl diacetyl tartrate , succinic acid monoglyceride, glycerol monofatty acid ester, glyceryl diglyceride fatty acid ester, polyglycerol fatty acid ester, polyglycerol condensed ricinoleic acid ester, etc. Glycerin fatty acid esters may be used alone or in combination of two or more.

甘油脂肪酸酯可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的甘油脂肪酸酯的例子,可列舉:艾麥斯(EMAX)BW-36(理研維他命股份有限公司)、泡艾慕(POEM)S-100(理研維他命股份有限公司)、桑索芙特(SUNSOFT)Q-17D(太陽化學股份有限公司)、泡艾慕(POEM)J-4081V(理研維他命股份有限公司)等。Glycerin fatty acid ester may be a natural product or a synthetic product, and may be obtained from a commercial source or obtained from a commercial source, and is not particularly limited. Examples of commercially available glycerin fatty acid esters include: EMAX BW-36 (Riken Vitamin Co., Ltd.), POEM S-100 (Riken Vitamin Co., Ltd.), Sansoft (SUNSOFT) Q-17D (Sun Chemical Co., Ltd.), POEM (POEM) J-4081V (Riken Vitamin Co., Ltd.), etc.

香葉木素為化學式C 16H 12O 6所表示的公知的物質,且作為CAS編號520-34-3而被人知。香葉木素可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的香葉木素的例子,可列舉Diosmetin(艾杜克生物科學(AdooQ Bioscience))等。 Dioxynignin is a known substance represented by the chemical formula C 16 H 12 O 6 and is known as CAS No. 520-34-3. The diosmin may be a natural product or a synthetic product, and may be obtained from a commercial source or obtained from a commercial source, and is not particularly limited. Examples of commercially available diosmetin include Diosmetin (AdooQ Bioscience) and the like.

次亞麻油酸為化學式C 18H 30O 2所表示的公知的物質,可例示α-次亞麻油酸、γ-次亞麻油酸等,較佳為可例示α-次亞麻油酸。次亞麻油酸可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的次亞麻油酸的例子,可列舉Linolenic Acid(東京化成工業股份有限公司)等。 Linolenic acid is a known substance represented by the chemical formula C 18 H 30 O 2 , and examples thereof include α-linolenic acid, γ-linolenic acid, and the like, preferably α-linolenic acid. Linolenic acid may be a natural product or a synthetic product, and may be obtained from a commercial source or obtained from a commercial source, and is not particularly limited. Examples of commercially available linolenic acid include Linolenic Acid (Tokyo Chemical Industry Co., Ltd.).

胡蘿蔔素為先前公知的物質,可例示α-胡蘿蔔素、β-胡蘿蔔素等,較佳為可例示β-胡蘿蔔素。胡蘿蔔素可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的胡蘿蔔素的例子,可列舉β-carotene(東京化成工業股份有限公司)等。Carotene is a conventionally known substance, and examples thereof include α-carotene, β-carotene, and the like, preferably β-carotene. Carotene may be a natural product or a synthetic product, and may be obtained from a commercial source or obtained from a commercial source, and is not particularly limited. Examples of commercially available carotene include β-carotene (Tokyo Chemical Industry Co., Ltd.).

大豆黃酮為化學式C 15H 10O 4所表示的公知的物質,且作為CAS編號486-66-8而被人知。大豆黃酮可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的大豆黃酮的例子,可列舉Daidzein(東京化成工業股份有限公司)等。 Daidzein is a known substance represented by the chemical formula C 15 H 10 O 4 and is known as CAS number 486-66-8. Daidzein may be a natural product or a synthetic product, and may be obtained commercially or from a commercially available product, and is not particularly limited. Examples of commercially available daidzein include Daidzein (Tokyo Chemical Industry Co., Ltd.).

橙皮苷為化學式C 28H 34O 15所表示的公知的多酚的一種,且作為CAS編號520-26-3而被人知。橙皮苷可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的橙皮苷的例子,可列舉Hesperidin(東京化成工業股份有限公司)等。 Hesperidin is one of known polyphenols represented by the chemical formula C 28 H 34 O 15 , and is known as CAS number 520-26-3. Hesperidin may be a natural product or a synthetic product, and may be obtained from a commercial source or obtained from a commercial source, and is not particularly limited. Examples of commercially available hesperidin include Hesperidin (Tokyo Chemical Industry Co., Ltd.).

金雀異黃酮為化學式C 15H 10O 5所表示的公知的物質,且作為CAS編號446-72-0而被人知。金雀異黃酮可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的金雀異黃酮的例子,可列舉Genistein(東京化成工業股份有限公司)等。 Genistein is a known substance represented by the chemical formula C 15 H 10 O 5 and is known as CAS number 446-72-0. Genistein may be a natural product or a synthetic product, and may be a commercially acquired substance or a substance obtained from a commercially acquired substance, and is not particularly limited. Examples of commercially available genistein include Genistein (Tokyo Chemical Industry Co., Ltd.).

柑橘萃取物為柑橘類的萃取物,雖並不限制本揭示,但作為柑橘類,可例示屬於橘科的蜜柑屬、金桔屬、枸橘屬等者,例如可列舉:柚子、臭橙(Kabosu)、橘子、臺灣香檬、金桔、文旦、橘等。關於該萃取物中使用的柑橘類的部位,只要可獲得本揭示的效果,則並無限制,主要可例示果實,例如可為果實其本身、果汁、其濃縮物、濃縮乾燥物等的任一種。柑橘類可單獨使用一種,亦可組合使用兩種以上,另外,其使用部位亦可單獨使用一種,亦可組合使用兩種以上。The citrus extract is an extract of citrus, and although this disclosure is not limited, examples of citrus include those belonging to the genus Satsuma, Kumquat, and Citrus belonging to the Citrus family, for example, yuzu, Kabosu , Tangerine, Taiwan lemon, kumquat, pomegranate, orange and so on. The parts of citrus fruits used in the extract are not limited as long as the effect of the present disclosure can be obtained, and fruits are mainly exemplified, for example, any of the fruit itself, fruit juice, its concentrate, and concentrated dried product. One kind of citrus fruits may be used alone, or two or more kinds may be used in combination, and the parts to be used may be used alone, or two or more kinds may be used in combination.

萃取物的製造方法(萃取方法)及萃取條件等並無特別限定,只要依據先前公知的方法即可。例如,可將柑橘類直接、視需要進行裁斷、粉碎、榨汁、乾燥等後,藉由溶媒萃取來獲得萃取物。作為溶媒萃取的方法,只要採用於本領域中公知的方法即可,例如可利用水(包括溫水、熱水)萃取、醇萃取、超臨界萃取等先前公知的萃取方法,視需要亦可進行攪拌等。針對所獲得的萃取液,視需要亦可進行過濾或離心分離等。The method for producing the extract (extraction method), extraction conditions, and the like are not particularly limited, as long as it follows a previously known method. For example, citrus fruit can be directly, if necessary, cut, pulverized, squeezed, dried, etc., and then extracted with a solvent to obtain an extract. As the method of solvent extraction, as long as the methods known in the art can be adopted, for example, previously known extraction methods such as water (including warm water, hot water) extraction, alcohol extraction, supercritical extraction, etc. can be used, and it can also be carried out if necessary. Stir and so on. The obtained extract may be filtered, centrifuged, or the like as necessary.

作為萃取溶媒,例如可列舉:水;甲醇、乙醇、異丙醇等低級醇或丙二醇、1,3-丁二醇等多元醇等醇類(可為無水、含水的任一種);丙酮等酮類、二乙醚、二噁烷、乙腈、乙酸乙酯等酯類、二甲苯、苯、氯仿等。作為溶媒,較佳為水、低級醇、1,3-丁二醇等,更佳為水、甲醇、乙醇、1,3-丁二醇,進而佳為水、甲醇、含水乙醇。該些萃取溶媒可單獨使用一種,亦可組合使用兩種以上。Examples of extraction solvents include water; alcohols such as lower alcohols such as methanol, ethanol, and isopropanol, or polyhydric alcohols such as propylene glycol and 1,3-butanediol (either anhydrous or water-containing); ketones such as acetone Classes, diethyl ether, dioxane, acetonitrile, ethyl acetate and other esters, xylene, benzene, chloroform, etc. The solvent is preferably water, lower alcohol, 1,3-butanediol, etc., more preferably water, methanol, ethanol, 1,3-butanediol, still more preferably water, methanol, or hydrous ethanol. These extraction solvents may be used alone or in combination of two or more.

於本揭示中,可將如上所述般經過溶媒萃取而獲得的萃取物特別稱為溶媒萃取物。另外,雖並不限制本揭示,但關於溶媒萃取物,例如於使用水作為萃取溶媒的情況下,可稱為水萃取物,於使用低級醇類作為萃取溶媒的情況下,可稱為低級醇萃取物,於使用乙醇作為萃取溶媒的情況下,可稱為乙醇萃取物等。In the present disclosure, the extract obtained through solvent extraction as described above may be specifically referred to as a solvent extract. In addition, although this disclosure is not limited, regarding solvent extracts, for example, in the case of using water as the extraction solvent, it can be called a water extract, and in the case of using lower alcohols as an extraction solvent, it can be called a lower alcohol. The extract, when ethanol is used as an extraction solvent, may be called an ethanol extract or the like.

所獲得的萃取物可以其原本的狀態使用,亦可進行乾燥而以粉末狀或顆粒狀等固體狀態使用。另外,視需要亦可對所獲得的萃取物進行超音波處理等,另外,亦可實施精製、濃縮處理、高活性分餾等分離處理等。另外,例如亦可針對所獲得的萃取物(進而其乾燥物、超音波處理物、精製處理物、濃縮處理物、高活性餾分等),依據供於凍結乾燥處理中並加以粉末化的方法等先前公知的方法而粉末化,從而製成本揭示中使用的萃取物。另外,視需要亦可將該萃取物溶解於水、乙醇等中來使用。The obtained extract may be used as it is, or may be dried and used in a solid state such as powder or granule. In addition, the obtained extract may be subjected to ultrasonic treatment, etc., if necessary, and may also be subjected to purification, concentration treatment, separation treatment such as high-activity fractionation, and the like. In addition, for example, the obtained extract (and its dried product, ultrasonic treatment product, purified product, concentrated product, highly active fraction, etc.) can also be subjected to freeze-drying treatment and powdered, etc. The extracts used in this disclosure were prepared by powdering by previously known methods. Moreover, this extract can also be used dissolved in water, ethanol, etc. as needed.

柑橘萃取物可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的柑橘萃取物的例子,可列舉柚子多酚(東洋精糖股份有限公司製造)等。柑橘萃取物可單獨使用一種,亦可組合使用兩種以上。The citrus extract may be commercially obtained or may be a substance obtained from a commercially obtained product, and is not particularly limited. As an example of a commercially available citrus extract, yuzu polyphenol (manufactured by Toyo Seisho Co., Ltd.) etc. are mentioned. Citrus extracts may be used alone or in combination of two or more.

黑生薑加工物為被稱為Kaempferia parviflora的薑科的植物的加工物,作為其使用部位,可為根莖(塊根)、葉、莖等的任一種,較佳為可列舉根莖。使用部位可單獨使用一種,亦可組合使用兩種以上。作為黑生薑加工物,可例示黑生薑的切片、粉碎物、乾燥物、榨汁、磨碎物、萃取物等。The processed black ginger is a processed product of a Zingiberaceae plant called Kaempferia parviflora, and the used part may be any of rhizome (tuber), leaf, stem, etc., preferably rhizome. One type may be used alone or two or more types may be used in combination. Examples of black ginger processed products include sliced, ground, dried, squeezed, ground, and extracts of black ginger.

切片若為利用先前公知的手段將黑生薑切片所得者,則並無限制。There are no restrictions on slices as long as black ginger is sliced by a conventionally known method.

粉碎物若為利用噴磨機等本領域中公知的粉碎手段將黑生薑粉碎所得者,則並無特別限制,可例示粉末、顆粒等。The pulverized product is not particularly limited as long as it is obtained by pulverizing black ginger by a pulverization means known in the art such as a jet mill, and powders, granules, and the like can be exemplified.

乾燥物若為使黑生薑乾燥所得者,則並無特別限制,可依據日曬乾燥、遠紅外線照射、乾燥機(熱風乾燥、冷風乾燥、真空凍結乾燥等)等先前公知的乾燥方法來獲得。作為乾燥物中的水分量,較佳為12質量%以下,更佳為10質量%以下。於本發明中,乾燥物的形態不限,可為黑生薑其本身的乾燥物、乾燥物的粉碎物等的任一種。乾燥粉碎物可依據與所述粉碎物相同的方法來獲得。另外,乾燥物亦可為將黑生薑發酵處理或酶處理後進行乾燥而獲得者。The dried product is not particularly limited as long as it is obtained by drying black ginger, and it can be obtained by conventionally known drying methods such as sun drying, far infrared radiation, drying machine (hot air drying, cold air drying, vacuum freeze drying, etc.) . The moisture content in the dried product is preferably at most 12% by mass, more preferably at most 10% by mass. In the present invention, the form of the dried product is not limited, and may be either a dried product of black ginger itself, a pulverized product of the dried product, or the like. The dry pulverized product can be obtained by the same method as the above-mentioned pulverized product. In addition, the dried product may be obtained by drying black ginger after fermentation treatment or enzyme treatment.

榨汁若為藉由先前公知的方法而自黑生薑獲得者,則並無限制。榨汁的形態亦可為液狀、糊狀、其乾燥物等的任一種,另外,亦可為該乾燥物的粉碎物等。The juice is not limited as long as it is obtained from black ginger by a previously known method. The form of the squeezed juice may be any of liquid, paste, and its dried product, and may also be a pulverized product of the dried product.

磨碎物若為利用先前公知的方法將黑生薑磨碎而獲得者,則並無限制。The ground product is not limited as long as it is obtained by grinding black ginger by a conventionally known method.

萃取物只要是使用黑生薑而獲得的萃取物即可,其製造方法(萃取方法)及萃取條件等並無特別限定,只要依據先前公知的方法即可。其製造方法可與所述同樣地進行說明。例如,可將黑生薑直接、視需要進行裁斷、粉碎、乾燥等後,藉由溶媒萃取來獲得萃取物。作為溶媒萃取的方法,例如可利用水(包括溫水、熱水)萃取、醇萃取、超臨界萃取等先前公知的萃取方法,視需要亦可進行攪拌等,針對所獲得的萃取液,視需要亦可進行過濾或離心分離等。作為萃取溶媒,可例示與所述相同者。可將如上所述般經過溶媒萃取而獲得的萃取物特別稱為溶媒萃取物,另外,關於在使用水作為萃取溶媒的情況下為水萃取物等,可與所述同樣地進行說明。The extract may be an extract obtained by using black ginger, and its production method (extraction method) and extraction conditions are not particularly limited, as long as it follows a conventionally known method. Its production method can be described in the same manner as above. For example, the extract can be obtained by extracting black ginger as it is, optionally after cutting, pulverizing, drying, etc., by solvent extraction. As a method of solvent extraction, for example, previously known extraction methods such as water (including warm water and hot water) extraction, alcohol extraction, and supercritical extraction can be used, and stirring can also be carried out if necessary. For the obtained extract, if necessary, Filtration or centrifugation can also be performed. As the extraction solvent, the same ones as those described above can be exemplified. The extract obtained by solvent extraction as described above can be particularly referred to as a solvent extract, and when water is used as an extraction solvent, it is a water extract, etc., and can be described in the same manner as above.

與所述同樣地,所獲得的萃取物可以其原本的狀態使用,亦可進行乾燥而以粉末狀或顆粒狀等固體狀態使用。另外,視需要亦可對所獲得的萃取物進行超音波處理等,另外,亦可實施精製、濃縮處理、高活性分餾等分離處理等。另外,例如亦可針對所獲得的萃取物(進而其乾燥物、超音波處理物、精製處理物、濃縮處理物、高活性餾分等),依據供於凍結乾燥處理中並加以粉末化的方法等先前公知的方法而粉末化,從而製成本揭示中使用的萃取物。另外,視需要亦可將該萃取物溶解於水、乙醇等中來使用。In the same manner as above, the obtained extract may be used as it is, or may be dried and used in a solid state such as powder or granule. In addition, the obtained extract may be subjected to ultrasonic treatment, etc., if necessary, and may also be subjected to purification, concentration treatment, separation treatment such as high-activity fractionation, and the like. In addition, for example, the obtained extract (and its dried product, ultrasonic treatment product, purified product, concentrated product, highly active fraction, etc.) can also be subjected to freeze-drying treatment and powdered, etc. The extracts used in this disclosure were prepared by powdering by previously known methods. Moreover, this extract can also be used dissolved in water, ethanol, etc. as needed.

黑生薑加工物可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的黑生薑加工物的例子,可列舉黑生薑萃取物(丸善製藥股份有限公司)、薩陶麥斯(SIRTMAX)(常磐植物化學研究所股份有限公司)等。黑生薑加工物可單獨使用一種,亦可組合使用兩種以上。The processed black ginger may be a commercially acquired product or a material obtained from a commercially acquired product, and is not particularly limited. Examples of commercially available black ginger processed products include black ginger extract (Maruzen Pharmaceutical Co., Ltd.), SIRTMAX (Tokiban Phytochemical Research Institute Co., Ltd.), and the like. One kind of processed black ginger may be used alone, or two or more kinds may be used in combination.

柚苷為化學式C 27H 32O 14所表示的公知的物質,且作為CAS編號10236-47-2而被人知。柚苷配基為柚苷的配基,且是化學式C 15H 12O 5所表示的公知的物質,且作為CAS編號480-41-1而被人知。該些可為天然產物,亦可為合成物,另外,可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的例子,可列舉Naringenin(開曼化學公司(Cayman Chemical Company))等。該些可單獨使用一種,亦可組合使用兩種以上。 Naringin is a known substance represented by the chemical formula C 27 H 32 O 14 and is known as CAS No. 10236-47-2. Naringenin is a ligand of naringin, is a known substance represented by the chemical formula C 15 H 12 O 5 , and is known as CAS No. 480-41-1. These may be natural products or synthetics, and may be obtained from commercial sources or obtained from commercial sources, and are not particularly limited. Naringenin (Cayman Chemical Company) etc. are mentioned as an example which can be acquired commercially. These may be used alone or in combination of two or more.

該些成分(1)可單獨使用一種,亦可組合使用兩種以上。These components (1) may be used alone or in combination of two or more.

成分(2) 成分(2)可如以下般進行說明。紅麴為於麴原料中接種先前公知的紅麴菌並加以培養而獲得的紅麴。紅麴菌若為先前用於製造紅麴者,則並無限制,可例示屬於紅麴菌屬(Monascus)的絲狀菌等。雖並不限制本揭示,但作為屬於紅麴菌屬的絲狀菌,可例示:叢毛紅麴菌(Monascus pilosus)、紫紅麴菌(Monascus purpureus)、赤紅麴菌(Monascus anka)、紅色紅麴菌(Monascus ruber)、軟毛紅麴菌(Monascus pubigerus)、該些的變種、該些的變異株等。作為紅麴菌,更佳為可例示叢毛紅麴菌、紫紅麴菌、赤紅麴菌等,進而佳為可例示叢毛紅麴菌。紅麴菌可單獨使用一種,亦可組合使用兩種以上。 ingredients (2) Component (2) can be demonstrated as follows. Red yeast rice is the red yeast rice obtained by inoculating and culturing previously known red yeast rice fungus in the raw material of red yeast rice. The red yeast rice fungus is not limited as long as it has been used in the production of red yeast rice, and filamentous fungi belonging to the genus Monascus can be exemplified. Although this disclosure is not limited, examples of filamentous fungi belonging to the genus Monascus pilosus include Monascus pilosus, Monascus purpureus, Monascus anka, and Monascus purpureus. (Monascus ruber), Monascus pubigerus, variants of these, variants of these, etc. As the red yeast rice, more preferable examples include Rhodotorula pilosae, Rudosus purpurea, Rudos rubrum rubrum, and the like, and still more preferably, Rhodotorus pilosae can be exemplified. The red fermented yeast can be used alone or in combination of two or more.

作為麴原料,可較佳地例示穀類,雖並不限制本揭示,但作為穀類,可例示:精白米、胚芽米、發芽糙米、糙米、胚芽等米類;大豆、小豆等豆類;麥類;玉米;板栗等。大豆可為白大豆、黑豆、青豆等的任一種,另外,亦可為脫脂大豆、大豆胚軸、大豆整豆等的任一種。另外,作為麴原料,更佳為可例示米類,進而佳為可例示精白米。據此,作為紅麴,較佳為可例示米紅麴。另外,麴原料的形狀並無特別限制,可為粉狀、粒狀,另外,亦可為經破碎或粉碎的狀態者,其大小亦無限制。另外,麴原料可預先進行加熱處理,例如可為與水一起煮好的米飯或麥飯、蒸好的米飯或麥飯、煮豆等。麴原料可單獨使用一種,亦可組合使用兩種以上。As the raw material of koji, grains can be preferably exemplified, although this disclosure is not limited, examples of grains include rice such as polished white rice, germ rice, germinated brown rice, brown rice, and germ; beans such as soybeans and adzuki beans; wheat; Corn; Chestnut etc. The soybean may be any of white soybeans, black soybeans, lima beans, etc., and may be any of defatted soybeans, soybean hypocotyls, whole soybeans, and the like. Moreover, as a koji raw material, it is more preferable to illustrate rice, and it is more preferable to illustrate polished white rice. Accordingly, as the red yeast rice, rice red yeast rice is preferably exemplified. In addition, the shape of the koji raw material is not particularly limited, and may be powdery, granular, or crushed or pulverized, and its size is also not limited. In addition, the koji raw material may be heat-processed in advance, for example, rice or barley rice boiled with water, steamed rice or barley rice, boiled beans, etc. may be used. Koji raw materials may be used alone or in combination of two or more.

紅麴的製造方法並無特別限制,可列舉依據先前公知的程序而於麴原料中接種紅麴菌,於好氣條件下進行培養的方法。作為紅麴的製造方法,主要已知有固體培養法或液體培養法,本揭示中的紅麴可為利用任意方法而製造者,較佳為可例示利用固體培養法而製造者。紅麴可單獨使用一種,亦可組合使用兩種以上。雖並不限制本揭示,但通常固體培養法是指於進行了蒸等處理的麴原料中接種紅麴菌,於好氣條件下進行培養來製造紅麴的方法,液體培養法是指於向水中添加麴原料所得的液體培養基中接種紅麴菌,進行培養來製造紅麴的方法。於該製造中,視需要亦可適當使用紅麴所需的碳源、氮源等各種成分。於與紅麴菌接觸之前,麴原料可為進行了基於加熱、加壓等公知的手段的殺菌處理者。另外,製麴時的溫度只要能夠生養紅麴菌,則並無限制,例如可列舉20℃~40℃左右。The production method of red yeast rice is not particularly limited, and a method in which red yeast rice is inoculated into a raw material of red yeast rice according to a conventionally known procedure and cultured under aerobic conditions can be mentioned. As a method for producing red yeast rice, mainly a solid culture method or a liquid culture method is known, and the red yeast rice in the present disclosure may be produced by any method, preferably, one produced by a solid culture method can be exemplified. Red yeast rice can be used alone or in combination of two or more. Although this disclosure is not limited, generally, the solid culture method refers to the method of inoculating the red yeast rice fungus in the raw material of steamed rice, and cultures it under aerobic conditions to produce the red yeast rice. A method in which red yeast rice is produced by inoculating red yeast rice bacteria into a liquid medium obtained by adding raw rice yeast ingredients and culturing it. In this production, various components such as a carbon source and a nitrogen source required for red yeast rice can also be appropriately used as needed. The koji raw material may be sterilized by known means such as heating and pressurization before being brought into contact with the red koji fungus. In addition, the temperature at the time of koji production is not limited as long as it can grow the red yeast rice, for example, about 20°C to 40°C is mentioned.

如上所述般製造的紅麴可直接使用,亦可進一步進行處理而以加工物的形式使用。作為加工物,可例示:紅麴的乾燥物、研碎物(糊)、萃取物等。The red yeast rice produced as described above may be used as it is, or may be further processed and used as a processed product. Examples of the processed product include a dried product, a ground product (paste), an extract, and the like of red yeast rice.

關於加工物,例如,如上所述般製造的紅麴可為進一步實施乾燥步驟後的乾燥物,乾燥處理視需要可於藉由使用通常的蒸發器的減壓濃縮來進行濃縮等後,藉由噴霧乾燥、凍結乾燥、真空乾燥等來進行。於本揭示中,所謂紅麴的乾燥物,是指紅麴中的水分量為12質量%以下者。另外,例如亦可為於該乾燥步驟前進行加熱處理而使酶活性等失活或進行滅菌所得者。另外,此種乾燥後,亦可藉由破碎或粉碎處理而製成粉末物、顆粒狀等。另外,例如,研碎物(糊)可藉由將以所述方式獲得的紅麴研碎而製成糊狀物來獲得,另外,萃取物可利用任意的萃取溶媒對以所述方式獲得的紅麴、其乾燥物、糊狀物等進行萃取來獲得。萃取物可為將該萃取物進一步濃縮後的濃縮萃取物,亦可為將該些乾燥後的乾燥萃取物。Regarding the processed product, for example, red yeast rice produced as described above may be a dried product after further performing a drying step, and the drying treatment may be carried out after concentration by vacuum concentration using a normal evaporator, etc., if necessary, by Spray drying, freeze drying, vacuum drying, etc. are carried out. In the present disclosure, the dry product of red yeast rice refers to one in which the water content in red yeast rice is 12% by mass or less. In addition, for example, heat treatment may be performed before the drying step to inactivate enzyme activity or the like, or may be obtained by sterilizing. In addition, after such drying, it can also be made into powder, granule, etc. by crushing or pulverizing. In addition, for example, a ground product (paste) can be obtained by grinding the red yeast rice obtained in the above-described manner to make a paste, and the extract can be obtained by using an arbitrary extraction solvent for the obtained in the above-described manner. It is obtained by extracting red yeast rice, its dry matter, paste, etc. The extract may be a concentrated extract obtained by further concentrating the extract, or may be a dry extract obtained by drying the extract.

萃取物的製造方法(萃取方法)及萃取條件等可與所述同樣地進行說明,並無特別限定,只要依據先前公知的方法即可。作為溶媒萃取的方法,只要採用於本領域中公知的方法即可,例如可利用水(包括溫水、熱水)萃取、醇萃取、超臨界萃取等先前公知的萃取方法。於萃取中,視需要亦可進行攪拌等,另外,針對所獲得的萃取液,視需要亦可進行過濾或離心分離等。萃取溶媒可例示與所述相同者。與所述同樣地,可將如上所述般經過溶媒萃取而獲得的萃取物特別稱為溶媒萃取物,另外,關於在使用水作為萃取溶媒的情況下為水萃取物等,可與所述同樣地稱謂。另外,以所述方式獲得的萃取物可以其原本的狀態使用,亦可以將該萃取物濃縮後的濃縮萃取物的形式使用,亦可以經乾燥的粉末狀或顆粒狀等固體狀態的乾燥萃取物的形式使用。另外,視需要亦可對所獲得的萃取物實施超音波處理、以及精製、濃縮處理、高活性分餾的分離處理等。關於紅麴的萃取物,亦可與所述同樣地進行說明。The method for producing the extract (extraction method), extraction conditions, and the like can be described in the same manner as above, and are not particularly limited, as long as they follow conventionally known methods. As the method of solvent extraction, any method known in the art may be used. For example, previously known extraction methods such as water (including warm water and hot water) extraction, alcohol extraction, and supercritical extraction can be used. In extraction, stirring etc. may be performed as needed, and the obtained extract may be filtered, centrifuged, etc. as needed. As the extraction solvent, the same ones as mentioned above can be exemplified. In the same manner as described above, the extract obtained through solvent extraction as described above can be specifically referred to as a solvent extract. In addition, when water is used as an extraction solvent, it is a water extract, etc., and can be used in the same manner as described above. title. In addition, the extract obtained in the above manner can be used in its original state, can also be used in the form of a concentrated extract obtained by concentrating the extract, or can be used as a dry extract in a solid state such as a dried powder or granule. form used. In addition, the obtained extract may be subjected to ultrasonic treatment, purification, concentration treatment, separation treatment of high activity fractionation, and the like as necessary. The extract of red yeast rice can also be described in the same manner as above.

紅麴可為商業上獲取者,亦可為自商業上獲取者獲得的物質,並無特別限制。作為能夠商業上獲取的紅麴的例子,可自紅麴粉末F(豐日(Sun Rich)股份有限公司)、紅麴粉末K-F(八重垣(Yaegaki)醱酵技研股份有限公司)、紅麴液2000(八重垣(Yaegaki)醱酵技研股份有限公司)、米紅麴(粉末)(日東酶股份有限公司)獲取。Red yeast rice may be obtained commercially, or may be obtained from commercially obtained materials, and is not particularly limited. As examples of commercially available red yeast rice, available from Red yeast rice powder F (Sun Rich Co., Ltd.), Red yeast rice powder K-F (Yaegaki Yeast Technology Research Co., Ltd.), Red yeast rice liquid 2000 (Yaegaki (Yaegaki) Yeast Technology Research Co., Ltd.), rice red yeast rice (powder) (Nitto Enzyme Co., Ltd.).

成分(2)可單獨使用一種,亦可組合使用兩種以上。Component (2) may be used alone or in combination of two or more.

本揭示的組成物中,成分(1)、成分(2)的含量並無限制,可例示:該組成物中,成分(1)以乾燥物換算計為0.001質量%~90質量%,較佳為1質量%~85質量%,更佳為2質量%~80質量%。於在本揭示中說明含量的情況下,所謂乾燥物換算,是指於成分(1)、成分(2)各自中水分含量為12%以下。以下,關於乾燥物換算,可同樣地進行說明。In the composition disclosed in the present disclosure, the content of the component (1) and the component (2) is not limited, but for example, in the composition, the content of the component (1) is 0.001% by mass to 90% by mass in terms of dry matter, preferably It is 1 mass % - 85 mass %, More preferably, it is 2 mass % - 80 mass %. When describing the content in the present disclosure, the dry matter conversion means that the moisture content in each of the component (1) and the component (2) is 12% or less. Hereinafter, the dry matter conversion can be described similarly.

另外,本揭示的組成物中,成分(1)、成分(2)的含量並無限制,可例示:該組成物中,成分(2)以乾燥物換算計為0.01質量%~95質量%,較佳為0.1質量%~90質量%,更佳為0.5質量%~85質量%。In addition, in the composition of the present disclosure, the content of the component (1) and the component (2) is not limited, and it can be exemplified that in the composition, the component (2) is 0.01% by mass to 95% by mass in terms of dry matter, Preferably it is 0.1 mass % - 90 mass %, More preferably, it is 0.5 mass % - 85 mass %.

另外,本揭示的組成物中,成分(1)、成分(2)的含量並無限制,可例示:相對於成分(2)1質量份(乾燥物換算),成分(1)為0.001質量份~100質量份(乾燥物換算),較佳為可例示0.1質量份~10質量份,更佳為可例示1質量份~5質量份。成分(1)、成分(2)的含量可為所述數值範圍內的任意值的組合。以下相同。In addition, in the composition of the present disclosure, the content of the component (1) and the component (2) is not limited, and can be exemplified: 0.001 parts by mass of the component (1) with respect to 1 part by mass of the component (2) (in terms of dry matter) - 100 parts by mass (dried matter conversion), preferably 0.1 to 10 parts by mass, more preferably 1 to 5 parts by mass. The content of component (1) and component (2) may be any combination of values within the numerical range. The following are the same.

另外,雖並不限制本揭示,但於成分(1)為雙去甲氧基薑黃素的情況下,本揭示的組成物中,雙去甲氧基薑黃素以乾燥物換算計較佳為可例示0.01質量%~10質量%,更佳為可例示0.05質量%~5質量%。另外,成分(1)為雙去甲氧基薑黃素的情況下,雖並不限制本揭示,但本揭示的組成物中,成分(2)以乾燥物換算計較佳為可例示0.01質量%~50質量%,更佳為可例示0.1質量%~30質量%,進而佳為可例示1質量%~15質量%。另外,雖並不限制本揭示,但於成分(1)為雙去甲氧基薑黃素的情況下,本揭示的組成物中,以乾燥物換算計,相對於成分(2)1質量份,雙去甲氧基薑黃素較佳為可例示0.1質量份~10質量份,更佳為可例示0.25質量份~5質量份。In addition, although this disclosure is not limited, when component (1) is bisdemethoxycurcumin, in the composition of the present disclosure, bisdemethoxycurcumin is preferably exemplified in terms of dry matter. 0.01% by mass to 10% by mass, more preferably 0.05% by mass to 5% by mass. In addition, when component (1) is bisdemethoxycurcumin, although this disclosure is not limited, in the composition of this disclosure, component (2) is preferably 0.01% by mass to 0.01% by mass in terms of dry matter. 50% by mass, more preferably 0.1% by mass to 30% by mass, still more preferably 1% by mass to 15% by mass. In addition, although this disclosure is not limited, in the case where component (1) is bisdemethoxycurcumin, in the composition of the present disclosure, in terms of dry matter, relative to 1 part by mass of component (2), Bisdemethoxycurcumin is preferably 0.1 to 10 parts by mass, more preferably 0.25 to 5 parts by mass.

同樣地,雖並不限制本揭示,但於成分(1)為甘油脂肪酸酯的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。甘油脂肪酸酯較佳為0.1質量%~10質量%,更佳為0.3質量%~5質量%。成分(2)較佳為0.01質量%~50質量%,更佳為0.1質量%~10質量%,進而佳為0.3質量%~50質量%。相對於成分(2)1質量份,甘油脂肪酸酯較佳為0.1質量份~10質量份,更佳為0.25質量份~5質量份。Similarly, although this indication is not limited, when component (1) is glycerin fatty acid ester, in the composition of this indication, the following content can be respectively illustrated preferably in conversion of a dry matter. The glycerin fatty acid ester is preferably from 0.1% by mass to 10% by mass, more preferably from 0.3% by mass to 5% by mass. The component (2) is preferably from 0.01% by mass to 50% by mass, more preferably from 0.1% by mass to 10% by mass, still more preferably from 0.3% by mass to 50% by mass. The glycerin fatty acid ester is preferably 0.1 to 10 parts by mass, more preferably 0.25 to 5 parts by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為香葉木素的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。香葉木素較佳為0.01質量%~60質量%,更佳為1質量%~5質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,香葉木素較佳為0.001質量份~10質量份,更佳為0.01質量份~1質量份。Similarly, although this indication is not limited, when component (1) is diosmin, in the composition of this indication, the following content can respectively be illustrated preferably in conversion of a dry matter. The content of diosmin is preferably from 0.01% by mass to 60% by mass, more preferably from 1% by mass to 5% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The amount of diosmin is preferably from 0.001 to 10 parts by mass, more preferably from 0.01 to 1 part by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為次亞麻油酸的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。次亞麻油酸較佳為0.001質量%~60質量%,更佳為0.01質量%~30質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,次亞麻油酸較佳為0.1質量份~20質量份,更佳為1質量份~10質量份。Similarly, although this indication is not limited, when the component (1) is linolenic acid, in the composition of this indication, the following content can be respectively illustrated preferably in conversion of a dry matter. The amount of sublinolenic acid is preferably from 0.001% by mass to 60% by mass, more preferably from 0.01% by mass to 30% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The amount of sublinolenic acid is preferably from 0.1 to 20 parts by mass, more preferably from 1 to 10 parts by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為胡蘿蔔素的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。胡蘿蔔素較佳為0.1質量%~20質量%,更佳為0.1質量%~10質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,胡蘿蔔素較佳為0.001質量份~10質量份,更佳為0.01質量份~1質量份。Similarly, although this indication is not limited, when component (1) is carotene, in the composition of this indication, the following content can respectively be illustrated preferably in conversion of a dry matter. Carotene is preferably in the range of 0.1% by mass to 20% by mass, more preferably in the range of 0.1% by mass to 10% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The amount of carotene is preferably from 0.001 to 10 parts by mass, more preferably from 0.01 to 1 part by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為大豆黃酮的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。大豆黃酮較佳為1質量%~30質量%,更佳為5質量%~20質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,大豆黃酮較佳為0.01質量份~10質量份,更佳為0.1質量份~1質量份。Similarly, although this indication is not limited, when component (1) is daidzein, in the composition of this indication, the following content can be respectively illustrated preferably in conversion of a dry matter. As for daidzein, it is preferable that it is 1 mass % - 30 mass %, and it is more preferable that it is 5 mass % - 20 mass %. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The daidzein is preferably 0.01 to 10 parts by mass with respect to 1 part by mass of the component (2), more preferably 0.1 to 1 part by mass.

同樣地,雖並不限制本揭示,但於成分(1)為橙皮苷的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。橙皮苷較佳為0.1質量%~80質量%,更佳為1質量%~70質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,橙皮苷較佳為0.01質量份~20質量份,更佳為0.1質量份~10質量份。Similarly, although this indication is not limited, when component (1) is hesperidin, in the composition of this indication, the following content can respectively be illustrated preferably in conversion of a dry matter. Hesperidin is preferably 0.1% by mass to 80% by mass, more preferably 1% by mass to 70% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The amount of hesperidin is preferably from 0.01 to 20 parts by mass, more preferably from 0.1 to 10 parts by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為金雀異黃酮的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。金雀異黃酮較佳為1質量%~30質量%,更佳為5質量%~20質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,金雀異黃酮較佳為0.01質量份~10質量份,更佳為0.1質量份~1質量份。Similarly, although this disclosure is not limited, when the component (1) is genistein, in the composition of the present disclosure, the following contents can be respectively preferably illustrated in terms of dry matter. As for genistein, it is preferable that it is 1 mass % - 30 mass %, and it is more preferable that it is 5 mass % - 20 mass %. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The amount of genistein is preferably from 0.01 to 10 parts by mass, more preferably from 0.1 to 1 part by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為柑橘萃取物的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。柑橘萃取物較佳為1質量%~70質量%,更佳為10質量%~50質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,柑橘萃取物較佳為0.1質量份~10質量份,更佳為0.5質量份~5質量份。Similarly, although this indication is not limited, when component (1) is a citrus extract, in the composition of this indication, the following content can respectively be illustrated preferably in conversion of a dry matter. The citrus extract is preferably from 1% by mass to 70% by mass, more preferably from 10% by mass to 50% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The citrus extract is preferably from 0.1 to 10 parts by mass, more preferably from 0.5 to 5 parts by mass, relative to 1 part by mass of the component (2).

同樣地,雖並不限制本揭示,但於成分(1)為黑生薑加工物的情況下,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。黑生薑加工物較佳為1質量%~70質量%,更佳為10質量%~50質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,黑生薑加工物較佳為可例示0.1質量份~10質量份,更佳為可例示0.5質量份~5質量份。Similarly, although this indication is not limited, when component (1) is a black ginger processed product, in the composition of this indication, the following content can respectively be illustrated preferably in conversion of a dry matter. The black ginger processed product is preferably 1% by mass to 70% by mass, more preferably 10% by mass to 50% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The processed black ginger is preferably 0.1 to 10 parts by mass with respect to 1 part by mass of the component (2), more preferably 0.5 to 5 parts by mass.

同樣地,雖並不限制本揭示,但於成分(1)為柚苷及/或柚苷配基的情況下,作為該些的合計量,本揭示的組成物中,以乾燥物換算計,可分別較佳地例示下述含量。柚苷及/或柚苷配基(合計量)較佳為1質量%~70質量%,更佳為10質量%~50質量%。成分(2)較佳為1質量%~50質量%,更佳為3.3質量%~34質量%。相對於成分(2)1質量份,柚苷及/或柚苷配基(合計量)較佳為可例示0.1質量份~10質量份,更佳為可例示0.5質量份~5質量份。Similarly, although this disclosure is not limited, when the component (1) is naringin and/or naringenin, as the total amount of these, in the composition of the present disclosure, in terms of dry matter, The following contents can be preferably illustrated respectively. The content of naringin and/or naringenin (total amount) is preferably from 1% by mass to 70% by mass, more preferably from 10% by mass to 50% by mass. Component (2) is preferably 1% by mass to 50% by mass, more preferably 3.3% by mass to 34% by mass. The naringin and/or naringenin (total amount) is preferably 0.1 to 10 parts by mass, more preferably 0.5 to 5 parts by mass, relative to 1 part by mass of the component (2).

本揭示的組成物可為經口、非經口的任一種,較佳為以經口的形式使用。另外,該組成物的形態亦無限制,只要根據目的來適當設定即可,可為固體狀、半固體狀、液狀的任一種。據此,該組成物可為粉末劑、細粒劑、顆粒劑(包括乾式糖漿)、片劑、丸劑、膠囊劑(包括硬膠囊、軟膠囊)、口含片、可咀嚼片、凝膠狀、糊狀、乳膏狀、液劑、懸浮液、乳劑、噴霧劑、液狀形態的凍結乾燥物等的任一種。另外,例如於本揭示的組成物為固體狀的情況下,其可與水等混合使用。The composition of the present disclosure can be either oral or parenteral, and is preferably used in an oral form. In addition, the form of the composition is not limited, as long as it is appropriately set according to the purpose, and it may be any of solid, semi-solid, and liquid. Accordingly, the composition can be powder, fine granule, granule (including dry syrup), tablet, pill, capsule (including hard capsule, soft capsule), buccal tablet, chewable tablet, gel form , paste, cream, liquid, suspension, emulsion, spray, freeze-dried product in liquid form, etc. In addition, for example, when the composition of the present disclosure is in a solid state, it can be mixed with water or the like and used.

另外,該組成物的使用態樣亦無限制,只要根據目的來適當設定即可,可用作食品組成物(包括飲料、保健功能食品(包括特定保健用食品、營養功能食品、功能性標示食品、補充劑(supplement)等)、包括患病者用食品)、醫藥組成物、準藥品組成物、化妝品組成物、飼料組成物以及對於食品組成物、醫藥組成物、準藥品組成物、化妝品組成物、飼料組成物]等的添加劑等。In addition, there are no restrictions on the use of the composition, as long as it is appropriately set according to the purpose, it can be used as a food composition (including beverages, health functional foods (including specific health use foods, nutritional functional foods, functionally labeled foods) , supplements (supplement), etc.), including foods for patients), pharmaceutical compositions, quasi-drug compositions, cosmetic compositions, feed compositions, and for food compositions, pharmaceutical compositions, quasi-drug compositions, and cosmetic compositions food, feed composition] and other additives.

本揭示的組成物只要依據所述各種形態、使用態樣等中的先前公知的通常的程序來製造即可,只要將成分(1)、成分(2)、以及視需要的、不妨礙本揭示的效果的範圍內的、藥學上允許的成分、香妝品學上允許的成分、可食性的成分等任意成分混合等來製造即可。The composition of the present disclosure may be produced according to the previously known common procedures in the various forms, usage, etc., as long as component (1), component (2), and, if necessary, without prejudice to the present disclosure Any ingredients such as pharmaceutically acceptable ingredients, cosmetically acceptable ingredients, and edible ingredients within the range of the effect of the drug can be mixed and manufactured.

作為該任意成分,可例示:基劑(水、甲醇、乙醇、異丙醇等低級醇、丙二醇、1,3-丁二醇等多元醇等醇類(可為無水、含水的任一種)等)、賦形劑、崩解劑、稀釋劑、潤滑劑、香料、著色料、甜味料、矯味劑、懸浮劑、濕潤劑、乳化劑、可溶化劑、分散劑、緩衝劑、結合劑、滲透促進劑、穩定劑、增量劑、防腐劑、增黏劑、pH值調整劑、界面活性劑、塗佈劑、吸收促進劑、吸附劑、填充劑、抗氧化劑、清涼劑、被膜形成劑、凝膠化劑、胺基酸、酶、各種營養成分等。該些可單獨使用一種,亦可組合使用兩種以上,另外,其含量亦只要適當決定即可。Examples of such optional components include bases (water, lower alcohols such as methanol, ethanol, and isopropanol, alcohols such as polyhydric alcohols such as propylene glycol and 1,3-butanediol (either anhydrous or water-containing), etc. ), excipients, disintegrants, diluents, lubricants, spices, colorants, sweeteners, flavoring agents, suspending agents, wetting agents, emulsifiers, solubilizers, dispersants, buffers, binders, Penetration enhancer, stabilizer, extender, preservative, thickener, pH adjuster, surfactant, coating agent, absorption enhancer, adsorbent, filler, antioxidant, cooling agent, film forming agent , gelling agent, amino acid, enzyme, various nutrients, etc. These may be used individually by 1 type, and may be used in combination of 2 or more types, and what is necessary is just to determine the content also suitably.

於本揭示中,該組成物的對象者(對象動物)亦無限制,可例示人、人以外的哺乳動物等。作為人以外的哺乳動物,可例示小鼠、大鼠、豚鼠、兔、狗、貓、猴、豬、牛、馬等動物,較佳為可例示小鼠、大鼠、豚鼠、兔、狗、猴等動物。In the present disclosure, the subject (target animal) of the composition is also not limited, and examples include humans, mammals other than humans, and the like. Examples of mammals other than humans include animals such as mice, rats, guinea pigs, rabbits, dogs, cats, monkeys, pigs, cows, and horses, preferably mice, rats, guinea pigs, rabbits, dogs, monkeys and other animals.

本揭示的組成物對於對象者(對象動物)的應用量並無特別限制,只要根據對象者(對象動物)的體格、年齡、症狀、應用形態、使用目的等來適當設定即可。雖並不限制本發明,但於以經口的形式應用的情況下,可例示:作為1天投與(攝取)量,以體重60 kg的成人為基準,成分(2)(乾燥物換算)較佳為1 mg~50000 mg,更佳為10 mg~20000 mg、20 mg~10000 mg。該組成物可為每1天單次投與(攝取),亦可為多次投與(攝取)。於以非經口的形式應用的情況或應用於人以外的動物的情況下,其應用量、應用次數等只要基於該經口應用中的說明來適當決定即可。The application amount of the composition disclosed herein is not particularly limited, and may be appropriately set according to the physique, age, symptom, application form, purpose of use, etc. of the subject (target animal). Although the present invention is not limited, in the case of oral application, as an example, the daily dosage (ingestion) is based on an adult with a body weight of 60 kg, component (2) (dried matter conversion) Preferably it is 1 mg-50000 mg, more preferably 10 mg-20000 mg, 20 mg-10000 mg. This composition may be administered (ingested) once per day, or may be administered (ingested) multiple times. In the case of parenteral application or application to animals other than humans, the application amount, frequency of application, and the like may be appropriately determined based on the description in the oral application.

本揭示的組成物含有所述成分(1)與所述成分(2),且藉由將該些加以組合,於含有所述成分(1)的組成物中抗氧化作用被增強。特佳為:藉由將所述成分(1)與所述成分(2)加以組合,所述抗氧化作用被協同地增強。據此,亦可以說本揭示較佳為提供一種組成物,其藉由將所述成分(1)與所述成分(2)加以組合而協同地增強了其抗氧化作用。另外,據此,亦可以說本揭示提供一種抗氧化用組成物,其含有所述成分(1)與所述成分(2)。The composition of the present disclosure contains the above-mentioned component (1) and the above-mentioned component (2), and by combining them, the antioxidant effect is enhanced in the composition containing the above-mentioned component (1). It is particularly preferred that the antioxidant action is synergistically enhanced by combining the component (1) and the component (2). Accordingly, it can also be said that the present disclosure preferably provides a composition that synergistically enhances the antioxidant effect by combining the component (1) and the component (2). Moreover, based on this, it can also be said that this disclosure provides the composition for antioxidants containing the said component (1) and the said component (2).

據此,亦可以說本揭示另外提供一種組成物中的抗氧化作用增強方法,所述組成物含有所述成分(1),所述方法的特徵在於將所述成分(1)與所述成分(2)加以組合。另外,據此,亦可以說本揭示另外提供一種成分(2)的用途,其用於在含有所述成分(1)的組成物中增強抗氧化作用。於該方法、用途中,成分(1)、成分(2)、組成物、其製造方法、其他能夠調配的成分等均可與所述組成物的說明同樣地進行說明。 [實施例] Accordingly, it can also be said that the present disclosure additionally provides a method for enhancing the antioxidant effect in a composition containing the component (1), and the method is characterized in that the component (1) is combined with the component (2) To be combined. In addition, according to this, it can also be said that the present disclosure additionally provides a use of component (2), which is used to enhance the antioxidant effect in a composition containing the component (1). In this method and use, component (1), component (2), composition, its production method, other components that can be formulated, and the like can be described in the same manner as the description of the above-mentioned composition. [Example]

以下,示出例子來更詳細地說明本揭示,但本揭示並不限定於該些。Hereinafter, although an example is shown and this indication is demonstrated in more detail, this indication is not limited to these.

試驗例 1.試驗程序 所使用的成分 本試驗例中使用的成分如下所述。 [成分(1)] 雙去甲氧基薑黃素(商品名Bisdemethoxycurcumin、CAS編號24939-16-0、東京化成工業股份有限公司製造) 甘油脂肪酸酯(商品名艾麥斯(EMAX)BW-36、理研維他命股份有限公司製造) 香葉木素(商品名Diosmetin、艾杜克生物科學(AdooQ Bioscience)製造) 次亞麻油酸(商品名Linolenic Acid、東京化成工業股份有限公司製造) 胡蘿蔔素(商品名β-carotene、東京化成工業股份有限公司製造) 大豆黃酮(商品名Daidzein、東京化成工業股份有限公司製造) 橙皮苷(商品名Hesperidin、東京化成工業股份有限公司製造) 金雀異黃酮(商品名Genistein、東京化成工業股份有限公司製造) 柑橘萃取物(商品名柚子多酚、東洋精糖股份有限公司製造) 黑生薑(商品名黑生薑萃取物、丸善製藥股份有限公司製造) 柚苷配基(商品名Naringenin、開曼化學公司(Cayman Chemical Company)製造) Test case 1. Test procedure ingredients used The components used in this test example are as follows. [ingredient (1)] Bisdemethoxycurcumin (trade name Bisdemethoxycurcumin, CAS number 24939-16-0, manufactured by Tokyo Chemical Industry Co., Ltd.) Glycerin fatty acid ester (trade name EMAX BW-36, manufactured by Riken Vitamin Co., Ltd.) Diosmetin (trade name Diosmetin, manufactured by AdooQ Bioscience) Linolenic acid (trade name Linolenic Acid, manufactured by Tokyo Kasei Kogyo Co., Ltd.) Carotene (trade name β-carotene, manufactured by Tokyo Chemical Industry Co., Ltd.) Daidzein (trade name Daidzein, manufactured by Tokyo Chemical Industry Co., Ltd.) Hesperidin (trade name Hesperidin, manufactured by Tokyo Chemical Industry Co., Ltd.) Genistein (trade name Genistein, manufactured by Tokyo Chemical Industry Co., Ltd.) Citrus extract (trade name Yuzu polyphenols, manufactured by Toyo Seinose Co., Ltd.) Black Ginger (trade name Black Ginger Extract, manufactured by Maruzen Pharmaceutical Co., Ltd.) Naringenin (trade name Naringenin, manufactured by Cayman Chemical Company)

[比較成分] 洛伐他汀(商品名Lovastatin、東京化成工業股份有限公司製造) GABA(商品名4-胺基丁酸(4-aminobutyric acid)、富士軟片和光純藥股份有限公司製造) 甘胺酸(商品名Glycine、富士軟片和光純藥股份有限公司製造) 魚明膠(商品名明膠(gelatin)FGS-230、日皮(Nippi)股份有限公司製造) 豬明膠(商品名明膠(gelatin)AP-200、日皮(Nippi)股份有限公司製造) 牛明膠(商品名明膠(gelatin)HTH-175、日皮(Nippi)股份有限公司製造) 腺嘌呤(商品名Adenine、富士軟片和光純藥股份有限公司製造) D-甘露糖(商品名D(+)-Mannose、富士軟片和光純藥股份有限公司製造) [comparison ingredients] Lovastatin (trade name Lovastatin, manufactured by Tokyo Chemical Industry Co., Ltd.) GABA (trade name 4-aminobutyric acid, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Glycine (trade name Glycine, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Fish gelatin (trade name gelatin (gelatin) FGS-230, manufactured by Nippi Co., Ltd.) Porcine gelatin (trade name gelatin (gelatin) AP-200, manufactured by Nippi Co., Ltd.) Bovine gelatin (trade name gelatin (gelatin) HTH-175, manufactured by Nippi Co., Ltd.) Adenine (trade name Adenine, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) D-mannose (trade name D(+)-Mannose, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)

[成分(2)] 紅麴(粉末狀(乾燥物)、小林製藥股份有限公司製造、米紅麴100%、水分量12質量%;更具體而言,藉由在蒸米中接種紅麴菌叢毛紅麴菌(Monascus pilosus)NITE BP-412株,進行培養、滅菌、乾燥、粉碎(粉末狀)而獲得者) [Ingredient (2)] Red yeast rice (powdered (dried), manufactured by Kobayashi Pharmaceutical Co., Ltd., rice red yeast rice 100%, water content 12% by mass; more specifically, by inoculating steamed rice with the red yeast rice fungus Monascus pilosus NITE BP-412 strain obtained by culturing, sterilizing, drying, and crushing (powder)

抗氧化作用的評價 使用利用了1,1-二苯基-2-苦基肼(l,l-diphenyl-2-picrylhydrazyl,DPPH)法的抗氧化能力測定試劑盒(DPPH Antioxidant Assay Kit、同仁化學研究所公司製造),來評價抗氧化作用。 Evaluation of Antioxidant Effect Antioxidant capacity assay kit using 1,1-diphenyl-2-picrylhydrazyl (l,l-diphenyl-2-picrylhydrazyl, DPPH) method (DPPH Antioxidant Assay Kit, manufactured by Dojin Chemical Research Institute Co., Ltd.) , to evaluate the antioxidant effect.

具體而言,於96孔微板中,依據試劑盒程序,添加測定緩衝液(Assay buffer)(附屬於試劑盒)、1,1-二苯基-2-苦基肼(l,l-diphenyl-2-picrylhydrazyl,DPPH)溶液及試樣或奎諾二甲基丙烯酸酯(Trolox)溶液,使用板讀取器於25℃下測定517 nm下的吸光度30分鐘。根據測定30分鐘時點的517 nm的吸光度來評價抗氧化活性。於該評價中,依據試劑盒程序,將Trolox用作自由基消除劑(濃度100 μg/mL、80 μg/mL、60 μg/mL、40 μg/mL、0 μg/mL),製成517 nm下的吸光度的校準曲線。Trolox為具有抗氧化作用的物質(陽性對照)。使用所獲得的校準曲線,基於各孔中的吸光度來算出抗氧化活性(抗氧化能力(%))。Specifically, in a 96-well microplate, add assay buffer (Assay buffer) (attached to the kit), 1,1-diphenyl-2-picrylhydrazine (l,l-diphenyl -2-picrylhydrazyl, DPPH) solution and sample or quinol dimethacrylate (Trolox) solution, the absorbance at 517 nm was measured at 25°C for 30 minutes using a plate reader. Antioxidant activity was evaluated by measuring the absorbance at 517 nm at 30 minutes. In this evaluation, Trolox was used as a free radical scavenger (concentrations 100 μg/mL, 80 μg/mL, 60 μg/mL, 40 μg/mL, 0 μg/mL) according to the kit procedure, prepared at 517 nm The absorbance calibration curve below. Trolox is a substance with antioxidant effect (positive control). Using the obtained calibration curve, the antioxidant activity (antioxidative capacity (%)) was calculated based on the absorbance in each well.

試樣是以如下方式製備。分別量取所述各成分10 mg至微管(艾本德(Eppendorf)股份有限公司製造、1.5 mL)中,向各管中加入水或甲醇而設為1 mL,於各管內藉由渦流(vortex)來進行攪拌。繼而,於室溫(24℃)下超音波處理30分鐘,離心處理後(10,000 g、25℃、10分鐘),回收上清液。自以所述方式獲得的溶液(10 mg/mL)中分取100 μL,利用水或甲醇適當稀釋而製備各濃度的試樣(5 mg/mL、2.5 mg/mL、1.25 mg/mL溶液)。以後述的表中所示的質量比使用如上所述般製備的試樣。再者,所述成分中,當為GABA、甘胺酸、魚明膠、豬明膠、牛明膠、腺嘌呤、D-甘露糖、紅麴時,使用水,當為其他成分時,使用甲醇。Samples were prepared in the following manner. Measure 10 mg of each of the above components into microtubes (manufactured by Eppendorf Co., Ltd., 1.5 mL), add water or methanol to each tube to make it 1 mL, and vortex each tube (vortex) for stirring. Then, ultrasonic treatment was performed at room temperature (24° C.) for 30 minutes, and after centrifugation (10,000 g, 25° C., 10 minutes), the supernatant was collected. 100 μL was aliquoted from the solution (10 mg/mL) obtained in the above manner, and appropriately diluted with water or methanol to prepare samples of each concentration (5 mg/mL, 2.5 mg/mL, 1.25 mg/mL solutions) . The samples prepared as described above were used at the mass ratios shown in the table below. In addition, among the above-mentioned components, water was used for GABA, glycine, fish gelatin, porcine gelatin, bovine gelatin, adenine, D-mannose, and red yeast rice, and methanol was used for other components.

所述DPPH溶液是以如下方式製備:向附屬於試劑盒的DPPH試劑(DPPH Reagent)(2 mL管)中加入1 mL的99.5%甲醇,進行60秒鐘超音波處理,利用99.5%甲醇將管內清洗3次,利用量瓶定容至10 mL。Trolox溶液是向放入有1 mg的Trolox的2 mL管中加入1 mL的99.5%乙醇,藉由渦流來進行混合。之後,進行10分鐘超音波處理,使內含物完全溶解。其次,利用99.5%甲醇將2 mL管內清洗3次,定容至10 mL。將其製成100 μg/mL,利用99.5%乙醇進行稀釋,同時製成80 μg/mL、60 μg/mL、40 μg/mL溶液,從而製成所述校準曲線用試樣。與所述試樣反應時,每1孔,將DPPH溶液設為100 μL,將各試樣溶液設為10 μL,將合計量(DPPH溶液、試樣溶液及測定緩衝液)設為200 μL。於陽性對照中,除使用10 μL的Trolox溶液來代替試樣溶液以外,設為相同。The DPPH solution is prepared in the following manner: add 1 mL of 99.5% methanol to the DPPH Reagent (2 mL tube) attached to the kit, perform ultrasonic treatment for 60 seconds, and use 99.5% methanol to dissolve the tube Wash for 3 times, and use a volumetric flask to set the volume to 10 mL. For the Trolox solution, add 1 mL of 99.5% ethanol to a 2 mL tube containing 1 mg of Trolox, and mix by vortexing. Afterwards, ultrasonic treatment was carried out for 10 minutes to completely dissolve the contents. Next, wash the inside of the 2 mL tube three times with 99.5% methanol, and dilute to 10 mL. This was prepared to 100 μg/mL, diluted with 99.5% ethanol, and simultaneously prepared into 80 μg/mL, 60 μg/mL, and 40 μg/mL solutions to prepare the samples for the calibration curve. When reacting with the sample, the DPPH solution was 100 μL per well, each sample solution was 10 μL, and the total amount (DPPH solution, sample solution, and measurement buffer) was 200 μL. In the positive control, it was the same except that 10 μL of Trolox solution was used instead of the sample solution.

結果 將結果示於表1~表18中。 result The results are shown in Tables 1 to 18.

[表1] 試樣 比較例1 比較例2 比較例3 比較例4 實施例1 實施例2 實施例3 紅麴 5 2.5 - - 5 5 2.5 雙去甲氧基薑黃素 - - 10 1.25 10 1.25 10 算出值 0 0 27.7 38.9 32.7 48.9 40.6 抗氧化理論值(和) - - - - 27.7 38.9 27.7 [Table 1] sample Comparative example 1 Comparative example 2 Comparative example 3 Comparative example 4 Example 1 Example 2 Example 3 red yeast rice 5 2.5 - - 5 5 2.5 Bisdemethoxycurcumin - - 10 1.25 10 1.25 10 calculated value 0 0 27.7 38.9 32.7 48.9 40.6 Antioxidant theoretical value (and) - - - - 27.7 38.9 27.7

[表2] 試樣 比較例1 比較例5 比較例6 比較例7 比較例8 實施例4 實施例5 實施例6 實施例7 實施例8 實施例9 紅麴 5 - - - - 5 5 5 5 2.5 2.5 甘油脂肪酸酯 - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 算出值 0 0 0 0 0 19.8 19.9 13.6 12.6 12.6 5 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 [Table 2] sample Comparative example 1 Comparative Example 5 Comparative example 6 Comparative Example 7 Comparative Example 8 Example 4 Example 5 Example 6 Example 7 Example 8 Example 9 red yeast rice 5 - - - - 5 5 5 5 2.5 2.5 Glycerin Fatty Acid Ester - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 calculated value 0 0 0 0 0 19.8 19.9 13.6 12.6 12.6 5 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0

[表3] 試樣 比較例1 比較例9 比較例10 比較例11 比較例12 實施例10 實施例11 實施例12 實施例13 實施例14 紅麴 5 - - - - 5 5 2.5 2.5 2.5 香葉木素 - 10 5 2.5 1.25 10 1.25 10 2.5 1.25 算出值 0 0 0 0 0 16 12.1 12.6 9.1 8.3 抗氧化理論值(和) - - - - - 0 0 0 0 0 [table 3] sample Comparative example 1 Comparative Example 9 Comparative Example 10 Comparative Example 11 Comparative Example 12 Example 10 Example 11 Example 12 Example 13 Example 14 red yeast rice 5 - - - - 5 5 2.5 2.5 2.5 diosmin - 10 5 2.5 1.25 10 1.25 10 2.5 1.25 calculated value 0 0 0 0 0 16 12.1 12.6 9.1 8.3 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0

[表4] 試樣 比較例1 比較例13 比較例14 比較例15 實施例15 實施例16 實施例17 實施例18 紅麴 5 - - - 5 5 2.5 2.5 次亞麻油酸 - 5 2.5 1.25 2.5 1.25 10 2.5 算出值 0 0 0 0 12.3 12.2 15 7 抗氧化理論值(和) - - - - 0 0 0 0 [Table 4] sample Comparative example 1 Comparative Example 13 Comparative Example 14 Comparative Example 15 Example 15 Example 16 Example 17 Example 18 red yeast rice 5 - - - 5 5 2.5 2.5 linolenic acid - 5 2.5 1.25 2.5 1.25 10 2.5 calculated value 0 0 0 0 12.3 12.2 15 7 Antioxidant theoretical value (and) - - - - 0 0 0 0

[表5] 試樣 比較例1 比較例16 比較例17 比較例18 比較例19 實施例19 實施例20 實施例21 實施例22 實施例23 實施例24 實施例25 紅麴 5 - - - - 5 5 5 5 2.5 2.5 2.5 胡蘿蔔素 - 10 5 2.5 1.25 10 5 2.5 1.25 5 2.5 1.25 算出值 0 0 0 0 0 23.5 18.1 13.2 14.4 5.8 5.4 5.7 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 0 [table 5] sample Comparative example 1 Comparative Example 16 Comparative Example 17 Comparative Example 18 Comparative Example 19 Example 19 Example 20 Example 21 Example 22 Example 23 Example 24 Example 25 red yeast rice 5 - - - - 5 5 5 5 2.5 2.5 2.5 carotene - 10 5 2.5 1.25 10 5 2.5 1.25 5 2.5 1.25 calculated value 0 0 0 0 0 23.5 18.1 13.2 14.4 5.8 5.4 5.7 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0 0

[表6] 試樣 比較例1 比較例20 比較例21 比較例22 比較例23 實施例26 實施例27 實施例28 實施例29 紅麴 5 - - - - 5 5 5 5 大豆黃酮 - 10 5 2.5 1.25 10 5 2.5 1.25 算出值 0 0 0 0 0 8.7 8 7.8 7.8 抗氧化理論值(和) - - - - - 0 0 0 0 [Table 6] sample Comparative example 1 Comparative Example 20 Comparative Example 21 Comparative Example 22 Comparative Example 23 Example 26 Example 27 Example 28 Example 29 red yeast rice 5 - - - - 5 5 5 5 daidzein - 10 5 2.5 1.25 10 5 2.5 1.25 calculated value 0 0 0 0 0 8.7 8 7.8 7.8 Antioxidant theoretical value (and) - - - - - 0 0 0 0

[表7] 試樣 比較例1 比較例24 比較例25 比較例26 比較例27 實施例30 實施例31 實施例32 紅麴 5 - - - - 5 5 2.5 橙皮苷 - 10 5 2.5 1.25 2.5 1.25 2.5 算出值 0 4.3 0 0 0 8.9 6.3 4.1 抗氧化理論值(和) - - - - - 0 0 0 [Table 7] sample Comparative example 1 Comparative Example 24 Comparative Example 25 Comparative Example 26 Comparative Example 27 Example 30 Example 31 Example 32 red yeast rice 5 - - - - 5 5 2.5 Hesperidin - 10 5 2.5 1.25 2.5 1.25 2.5 calculated value 0 4.3 0 0 0 8.9 6.3 4.1 Antioxidant theoretical value (and) - - - - - 0 0 0

[表8] 試樣 比較例1 比較例28 比較例29 比較例30 比較例31 實施例33 實施例34 實施例35 實施例36 實施例37 實施例38 紅麴 5 - - - - 5 5 5 5 2.5 2.5 金雀異黃酮 - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 算出值 0 10.2 5.4 0 0 23.2 12.8 6.8 4.6 23.5 9.2 抗氧化理論值(和) - - - - - 10.2 5.4 0 0 10.2 5.4 [Table 8] sample Comparative example 1 Comparative Example 28 Comparative Example 29 Comparative Example 30 Comparative Example 31 Example 33 Example 34 Example 35 Example 36 Example 37 Example 38 red yeast rice 5 - - - - 5 5 5 5 2.5 2.5 Genistein - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 calculated value 0 10.2 5.4 0 0 23.2 12.8 6.8 4.6 23.5 9.2 Antioxidant theoretical value (and) - - - - - 10.2 5.4 0 0 10.2 5.4

[表9] 試樣 比較例1 比較例32 比較例33 比較例34 比較例35 實施例39 實施例40 實施例41 實施例42 紅麴 5 - - - - 5 5 2.5 2.5 柑橘萃取物 - 10 5 2.5 1.25 10 5 10 5 算出值 0 0 0 0 0 12.7 6.3 13.6 5 抗氧化理論值(和) - - - - - 0 0 0 0 [Table 9] sample Comparative example 1 Comparative Example 32 Comparative Example 33 Comparative Example 34 Comparative Example 35 Example 39 Example 40 Example 41 Example 42 red yeast rice 5 - - - - 5 5 2.5 2.5 Citrus Extract - 10 5 2.5 1.25 10 5 10 5 calculated value 0 0 0 0 0 12.7 6.3 13.6 5 Antioxidant theoretical value (and) - - - - - 0 0 0 0

[表10] 試樣 比較例1 比較例36 比較例37 比較例38 比較例39 實施例43 實施例44 實施例45 紅麴 5 - - - - 5 2.5 2.5 黑生薑 - 10 5 2.5 1.25 5 10 5 算出值 0 0 0 0 0 14.3 14.4 6.1 抗氧化理論值(和) - - - - - 0 0 0 [Table 10] sample Comparative example 1 Comparative Example 36 Comparative Example 37 Comparative Example 38 Comparative Example 39 Example 43 Example 44 Example 45 red yeast rice 5 - - - - 5 2.5 2.5 black ginger - 10 5 2.5 1.25 5 10 5 calculated value 0 0 0 0 0 14.3 14.4 6.1 Antioxidant theoretical value (and) - - - - - 0 0 0

[表11] 試樣 比較例1 比較例40 比較例41 比較例42 比較例43 實施例46 實施例47 實施例48 實施例49 實施例50 實施例51 實施例52 實施例53 紅麴 5 - - - - 5 5 5 5 2.5 2.5 2.5 2.5 柚苷配基 - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 2.5 1.25 算出值 0 0 0 0 0 12.6 12.5 11.4 13 22 15.7 13.6 9.1 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 0 0 [Table 11] sample Comparative example 1 Comparative Example 40 Comparative Example 41 Comparative Example 42 Comparative Example 43 Example 46 Example 47 Example 48 Example 49 Example 50 Example 51 Example 52 Example 53 red yeast rice 5 - - - - 5 5 5 5 2.5 2.5 2.5 2.5 Naringenin - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 2.5 1.25 calculated value 0 0 0 0 0 12.6 12.5 11.4 13 twenty two 15.7 13.6 9.1 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0 0 0

[表12] 試樣 比較例1 比較例44 比較例45 實施例46 實施例47 比較例48 比較例49 比較例50 比較例51 比較例52 比較例53 紅麴 5 - - - - 5 5 2.5 2.5 2.5 2.5 洛伐他汀 - 10 5 2.5 1.25 10 5 10 5 2.5 1.25 算出值 0 0 0 0 0 0 0 0 0 0 0 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 [Table 12] sample Comparative example 1 Comparative Example 44 Comparative Example 45 Example 46 Example 47 Comparative Example 48 Comparative Example 49 Comparative Example 50 Comparative Example 51 Comparative Example 52 Comparative Example 53 red yeast rice 5 - - - - 5 5 2.5 2.5 2.5 2.5 lovastatin - 10 5 2.5 1.25 10 5 10 5 2.5 1.25 calculated value 0 0 0 0 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0

[表13] 試樣 比較例1 比較例54 比較例55 比較例56 比較例57 比較例58 比較例59 比較例60 比較例61 比較例62 比較例63 比較例64 比較例65 紅麴 5 - - - - 5 5 5 5 2.5 2.5 2.5 2.5 GABA - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 2.5 1.25 算出值 0 0 0 0 0 0 0 0 0 0 0 0 0 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 0 0 [Table 13] sample Comparative example 1 Comparative Example 54 Comparative Example 55 Comparative Example 56 Comparative Example 57 Comparative Example 58 Comparative Example 59 Comparative example 60 Comparative Example 61 Comparative Example 62 Comparative Example 63 Comparative Example 64 Comparative Example 65 red yeast rice 5 - - - - 5 5 5 5 2.5 2.5 2.5 2.5 GABA - 10 5 2.5 1.25 10 5 2.5 1.25 10 5 2.5 1.25 calculated value 0 0 0 0 0 0 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0 0 0

[表14] 試樣 比較例1 比較例66 比較例67 比較例68 比較例69 比較例70 比較例71 比較例72 比較例73 比較例74 比較例75 比較例76 紅麴 5 - - - - 5 5 5 2.5 2.5 2.5 2.5 甘胺酸 - 10 5 2.5 1.25 5 2.5 1.25 10 5 2.5 1.25 算出值 0 0 0 0 0 0 0 0 0 0 0 0 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 0 [Table 14] sample Comparative example 1 Comparative Example 66 Comparative Example 67 Comparative Example 68 Comparative Example 69 Comparative example 70 Comparative Example 71 Comparative Example 72 Comparative Example 73 Comparative Example 74 Comparative Example 75 Comparative Example 76 red yeast rice 5 - - - - 5 5 5 2.5 2.5 2.5 2.5 Glycine - 10 5 2.5 1.25 5 2.5 1.25 10 5 2.5 1.25 calculated value 0 0 0 0 0 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0 0

[表15] 試樣 比較例1 比較例77 比較例78 比較例79 比較例80 比較例81 比較例82 紅麴 5 - - - - 2.5 2.5 魚明膠 - 10 5 2.5 1.25 10 5 算出值 0 0 0 0 0 0 0 抗氧化理論值(和) - - - - - 0 0 [Table 15] sample Comparative example 1 Comparative Example 77 Comparative Example 78 Comparative Example 79 Comparative example 80 Comparative Example 81 Comparative Example 82 red yeast rice 5 - - - - 2.5 2.5 fish gelatin - 10 5 2.5 1.25 10 5 calculated value 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - - - - 0 0

[表16] 試樣 比較例1 比較例83 比較例84 比較例85 比較例86 比較例87 比較例88 比較例89 比較例90 紅麴 5 - 2.5 - - - 2.5 2.5 2.5 豬明膠 - 5 5 - - - - - - 牛明膠 - - - 5 2.5 1.25 5 2.5 1.25 算出值 0 0 0 0 0 0 0 0 0 抗氧化理論值(和) - - 0 - - - 0 0 0 [Table 16] sample Comparative example 1 Comparative Example 83 Comparative Example 84 Comparative example 85 Comparative Example 86 Comparative Example 87 Comparative Example 88 Comparative Example 89 Comparative example 90 red yeast rice 5 - 2.5 - - - 2.5 2.5 2.5 Porcine Gelatin - 5 5 - - - - - - bovine gelatin - - - 5 2.5 1.25 5 2.5 1.25 calculated value 0 0 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - 0 - - - 0 0 0

[表17] 試樣 比較例1 比較例91 比較例92 比較例93 比較例94 比較例95 比較例96 比較例97 比較例98 比較例99 比較例100 比較例101 紅麴 5 - - - - 5 5 5 2.5 2.5 2.5 2.5 腺嘌呤 - 10 5 2.5 1.25 10 5 2.5 10 5 2.5 1.25 算出值 0 0 0 0 0 0 0 0 0 0 0 0 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 0 [Table 17] sample Comparative example 1 Comparative Example 91 Comparative Example 92 Comparative example 93 Comparative example 94 Comparative example 95 Comparative example 96 Comparative Example 97 Comparative example 98 Comparative Example 99 Comparative example 100 Comparative Example 101 red yeast rice 5 - - - - 5 5 5 2.5 2.5 2.5 2.5 adenine - 10 5 2.5 1.25 10 5 2.5 10 5 2.5 1.25 calculated value 0 0 0 0 0 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0 0

[表18] 試樣 比較例1 比較例102 比較例103 比較例104 比較例105 比較例106 比較例107 比較例108 比較例109 比較例110 比較例111 比較例112 紅麴 5 - - - - 5 5 5 2.5 2.5 2.5 2.5 D-甘露糖 - 10 5 2.5 1.25 10 5 2.5 10 5 2.5 1.25 算出值 0 0 0 0 0 0 0 0 0 0 0 0 抗氧化理論值(和) - - - - - 0 0 0 0 0 0 0 [Table 18] sample Comparative example 1 Comparative Example 102 Comparative Example 103 Comparative Example 104 Comparative Example 105 Comparative Example 106 Comparative Example 107 Comparative Example 108 Comparative Example 109 Comparative Example 110 Comparative Example 111 Comparative Example 112 red yeast rice 5 - - - - 5 5 5 2.5 2.5 2.5 2.5 D-Mannose - 10 5 2.5 1.25 10 5 2.5 10 5 2.5 1.25 calculated value 0 0 0 0 0 0 0 0 0 0 0 0 Antioxidant theoretical value (and) - - - - - 0 0 0 0 0 0 0

表中,於比較例1中,「5」是指將如上所述般製備的5 mg/mL的紅麴溶液用作試樣,於比較例3中,「10」是指將10 mg/mL的雙去甲氧基薑黃素溶液用作試樣,於實施例1中,「5」、「10」是指將5 mg/mL的紅麴溶液與10 mg/mL的雙去甲氧基薑黃素溶液用作試樣。其他實施例、比較例亦相同。另外,表中,「算出值」表示如上所述般算出的抗氧化活性(抗氧化能力(%))。如表1所示般,於僅使用紅麴的比較例1、比較例2中,抗氧化能力均為0%,於僅使用雙去甲氧基薑黃素的比較例3、比較例4中,抗氧化能力分別為27.7%、38.9%。In the table, in Comparative Example 1, "5" means that the 5 mg/mL red yeast rice solution prepared as above was used as a sample, and in Comparative Example 3, "10" means that 10 mg/mL The bisdemethoxycurcumin solution of 10 mg/mL of bisdemethoxycurcumin is used as a sample. solution was used as a sample. The same applies to other Examples and Comparative Examples. In addition, in the table, "calculated value" represents the antioxidant activity (antioxidative capacity (%)) calculated as mentioned above. As shown in Table 1, in Comparative Example 1 and Comparative Example 2 that only use red yeast rice, the antioxidant capacity is 0%, and in Comparative Example 3 and Comparative Example 4 that only use bisdemethoxycurcumin, Antioxidant capacity were 27.7%, 38.9%.

相對於此,於併用紅麴與雙去甲氧基薑黃素的實施例1及實施例2中,抗氧化作用協同地增強。具體而言,實施例1為組合使用與比較例1為相同量的紅麴及與比較例3為相同量的雙去甲氧基薑黃素的例子,當根據比較例1(抗氧化能力0%)與比較例3(抗氧化能力27.7%)來判斷時,儘管預想為即便將比較例1與比較例3加以組合,抗氧化能力亦最多為27.7%(0%+27.7%,表中,實施例1的「抗氧化理論值(和)」),但實際上於實施例1中,抗氧化能力協同地提高至32.7%。另外,實施例2為組合使用與比較例1為相同量的紅麴及與比較例4為相同量的雙去甲氧基薑黃素的例子,當根據比較例1(抗氧化能力0%)與比較例4(抗氧化能力38.9%)來判斷時,儘管預想為即便將比較例1與比較例4加以組合,抗氧化能力亦最多為38.9%(0%+38.9%,表中,實施例1的「抗氧化理論值(和)」),但實際上所述抗氧化能力協同地提高至48.9%。據此,得知:藉由組合使用紅麴與雙去甲氧基薑黃素,可協同地增強雙去甲氧基薑黃素的抗氧化作用。In contrast, in Example 1 and Example 2 in which red yeast rice and bisdemethoxycurcumin were used in combination, the antioxidant effect was synergistically enhanced. Specifically, Example 1 is an example in which the same amount of red yeast rice as in Comparative Example 1 and the same amount of bisdemethoxycurcumin as in Comparative Example 3 are used in combination. ) and Comparative Example 3 (antioxidant capacity 27.7%), although it is expected that even if Comparative Example 1 and Comparative Example 3 are combined, the antioxidant capacity is at most 27.7% (0% + 27.7%, in the table, the implementation Example 1 "theoretical value of antioxidant (and)"), but actually in Example 1, the antioxidant capacity synergistically increased to 32.7%. In addition, Example 2 is an example in which the same amount of red yeast rice as in Comparative Example 1 and the same amount of bisdemethoxycurcumin as in Comparative Example 4 were used in combination. When judging from Comparative Example 4 (antioxidant capacity 38.9%), it is expected that even when Comparative Example 1 and Comparative Example 4 are combined, the antioxidant capacity is at most 38.9% (0% + 38.9%, in the table, Example 1 "Antioxidant theoretical value (and)"), but actually said antioxidant capacity synergistically increased to 48.9%. Accordingly, it was found that the antioxidant effect of bisdemethoxycurcumin can be enhanced synergistically by using red yeast rice and bisdemethoxycurcumin in combination.

另外,於使用甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物或柚苷配基來代替雙去甲氧基薑黃素的表2~表11中,亦成為相同的結果。據此,得知:紅麴對於該些成分亦可增強抗氧化作用。In addition, when using fatty acid esters of glycerol, diosmin, linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger processed product or naringenin instead of bis In Tables 2 to 11 of demethoxycurcumin, the same result was obtained. Accordingly, it is known that red yeast rice can also enhance the antioxidant effect on these components.

相對於此,於含有洛伐他汀、GABA、甘胺酸、魚明膠、豬明膠、牛明膠、腺嘌呤、D-甘露糖來代替雙去甲氧基薑黃素的組成物中,即便將該些成分與紅麴加以組合,於該組成物中亦未確認到抗氧化作用的增強。In contrast, in a composition containing lovastatin, GABA, glycine, fish gelatin, porcine gelatin, bovine gelatin, adenine, and D-mannose instead of bisdemethoxycurcumin, even if these The ingredients were combined with red yeast rice, and the enhancement of the antioxidant effect was not confirmed in this composition.

如上所述,得知:於含有雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷或柚苷配基的組成物中,藉由將該些成分與紅麴加以組合而可增強抗氧化作用。As mentioned above, it is found that: containing bisdemethoxy curcumin, glycerin fatty acid ester, diosmin, linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, In the composition of processed black ginger, naringin or naringenin, the antioxidation effect can be enhanced by combining these components with red yeast rice.

再者,例如,於使用甘油脂肪酸酯的表2中,於比較例1、比較例5中,抗氧化能力均為0%,於實施例4中,抗氧化能力為19.8%。推測其原因在於:雖然甘油脂肪酸酯原本具有抗氧化作用,但是於比較例5中,由於組成物中的甘油脂肪酸酯的含量少,因此抗氧化能力算出為0%,且於實施例4中,藉由併用甘油脂肪酸酯與紅麴而增強了抗氧化作用,結果抗氧化能力提高至19.8%(增強至可測定抗氧化作用的程度)。可以說於其他表中亦相同。Furthermore, for example, in Table 2 using glycerin fatty acid ester, in Comparative Example 1 and Comparative Example 5, the antioxidant capacity was 0%, and in Example 4, the antioxidant capacity was 19.8%. It is speculated that the reason is that although glycerin fatty acid ester originally has an antioxidant effect, in Comparative Example 5, since the content of glycerin fatty acid ester in the composition is small, the antioxidant capacity is calculated as 0%, and in Example 4 Among them, the antioxidant effect was enhanced by using fatty acid esters of glycerol and red yeast rice together, and as a result, the antioxidant capacity was increased to 19.8% (enhanced to the extent that the antioxidant effect can be measured). The same can be said for other tables.

處方例 於含有以下成分的組成物(組成物合計量每455 mg的成分含量)中,亦可藉由於甘油脂肪酸酯中組合紅麴來增強抗氧化作用。 米紅麴:100 mg 甘油脂肪酸酯:25 mg 紅花油:150 mg 明膠:130 mg 甘油:50 mg Prescription In the composition containing the following ingredients (total composition amount per 455 mg of ingredient content), the antioxidant effect can also be enhanced by combining red yeast rice with glycerin fatty acid ester. Rice red yeast rice: 100 mg Glycerin fatty acid esters: 25 mg Safflower oil: 150 mg Gelatin: 130 mg Glycerin: 50 mg

none

none

Claims (4)

一種組成物,含有下述成分(1)及成分(2): (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷及柚苷配基所組成的群組中的至少一種; (2)選自由紅麴及其加工物所組成的群組中的至少一種。 A composition comprising the following component (1) and component (2): (1) Processed from bis-demethoxy curcumin, glycerin fatty acid ester, diosmin, sub-linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger At least one of the group consisting of naringin, naringin and naringenin; (2) At least one selected from the group consisting of red yeast rice and its processed products. 如請求項1所述的組成物,用於經口用途。The composition as described in Claim 1, for oral use. 一種組成物中的抗氧化作用增強方法,所述組成物含有下述成分(1),所述方法的特徵在於將下述成分(1)與成分(2)加以組合: (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷及柚苷配基所組成的群組中的至少一種; (2)選自由紅麴及其加工物所組成的群組中的至少一種。 A method for enhancing antioxidation in a composition containing the following component (1), the method characterized by combining the following component (1) and component (2): (1) Processed from bis-demethoxy curcumin, glycerin fatty acid ester, diosmin, sub-linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger At least one of the group consisting of naringin, naringin and naringenin; (2) At least one selected from the group consisting of red yeast rice and its processed products. 一種選自由紅麴及其加工物所組成的群組中的至少一種的用途,用以於含有下述成分(1)的組成物中增強抗氧化作用: (1)選自由雙去甲氧基薑黃素、甘油脂肪酸酯、香葉木素、次亞麻油酸、胡蘿蔔素、大豆黃酮、橙皮苷、金雀異黃酮、柑橘萃取物、黑生薑加工物、柚苷及柚苷配基所組成的群組中的至少一種。 A use of at least one selected from the group consisting of red yeast rice and its processed products, for enhancing the antioxidant effect in a composition containing the following component (1): (1) Processed from bis-demethoxy curcumin, glycerin fatty acid ester, diosmin, sub-linolenic acid, carotene, daidzein, hesperidin, genistein, citrus extract, black ginger At least one of the group consisting of naringin, naringin and naringenin.
TW111115867A 2021-06-28 2022-04-26 Red yeast rice and composition containing specific components TW202306579A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-107058 2021-06-28
JP2021107058 2021-06-28

Publications (1)

Publication Number Publication Date
TW202306579A true TW202306579A (en) 2023-02-16

Family

ID=84691201

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111115867A TW202306579A (en) 2021-06-28 2022-04-26 Red yeast rice and composition containing specific components

Country Status (3)

Country Link
CN (1) CN117651499A (en)
TW (1) TW202306579A (en)
WO (1) WO2023276496A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3947721B2 (en) * 2003-03-28 2007-07-25 磐田化学工業株式会社 A culture of koji mold containing a physiologically active substance and a method for producing the same
JP2022087328A (en) * 2021-06-28 2022-06-09 小林製薬株式会社 Composition containing ang-khak and specific component

Also Published As

Publication number Publication date
WO2023276496A1 (en) 2023-01-05
CN117651499A (en) 2024-03-05

Similar Documents

Publication Publication Date Title
EP1637151A1 (en) Preventive or remedy for arthritis
KR101705548B1 (en) Composition for enhancing immune response comprising extract of Apios americana Medikus or fermented extract of the same
EP1407777B1 (en) Hydrangea(e) for the prevention or treatment of arthritis
JP2010265251A (en) Bloodstream-promoting/improving agent
US20040219238A1 (en) Remedies
JP5066725B2 (en) Fat absorption inhibitor, fat accumulation inhibitor or fat burning accelerator
JPWO2004112817A1 (en) Celery family-derived extract and method for producing the same
JP2006014730A (en) Food product
KR20180098736A (en) A composition having anti-oxidation or anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient
JP2004159563A (en) Propolis composition
JP2022087328A (en) Composition containing ang-khak and specific component
KR101790657B1 (en) Extraction of polysaccharides from pine nut cake and composition comprising pine nut extract for enhancement of immunity
TW202306579A (en) Red yeast rice and composition containing specific components
JP2008163004A (en) Fat accumulation inhibitor
JP2008163003A (en) Fat absorption inhibitor
JP7296611B2 (en) Nitric oxide production accelerator
KR20110121849A (en) Composition for prevention or treatment of obesity or hyperlipedemia comprising the extracts of gymnaster koraiensis or artemisia dubia
JP2008163005A (en) Fat combustion-promoting agent
KR101018404B1 (en) Compositions for reducing cholesterol comprising extracts of Vaccinium oldhami Miquel leaf as an active ingredient
KR101949557B1 (en) Composition for immune enhancing activity containingextract of aralia cordata
JP2005089385A (en) Lipoxygenase inhibitor
KR101624293B1 (en) Composition for enhancing immune response comprising extract of Benincasa hispida Cogniaux or fermented extract of the same
KR20150085215A (en) Composition comprising black garlic and Gastrodia elata extract with antioxidant activity and method of making the same
JP2018009038A (en) Oral composition
KR101800999B1 (en) Obesity inhibiting composition comprising powder of entire tangerine cultivated by eco friendly method